Skip to main content

Table 2 Percentage of patients with diabetes and control individuals reporting moderate and severe problems in each EQ-5D dimension by disease duration

From: Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15—34 years – a Swedish population-based study using EQ-5D

 

Diabetes duration

  
 

1 year

 

8 years

 

15 years

 

24 years

 

Comparison of individuals with diabetes

Comparison of control individuals

 

(2008 cohort)

 

(1999 cohort)

 

(1992 cohort)

 

(1983 cohort)

 
 

Individuals with diabetes

Control individuals

p a

Individuals with diabetes

Control individuals

p a

Individuals with diabetes

Control individuals

p a

Individuals with diabetes

Control individuals

p a

 

n = 141

n = 247

 

n = 208

n = 381

 

n = 225

n = 419

 

n = 265

n = 517

 

p b

p c

 

%

n

%

n

 

%

n

%

n

 

%

n

%

n

 

%

n

%

n

   

Mobility

                      

Women

                      

 Moderate problems

5.7

3

4.0

4

0.69

6.4

6

3.6

6

0.36

11.7

11

9.3

16

0.54

16.1

18

9.9

19

0.049

0.053

0.053

 Severe problems

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.9

1

0.0

0

   

Men

                      

 Moderate problems

2.3

2

2.7

4

1.00

2.6

3

5.6

12

0.22

10.7

14

4.9

12

0.033

17.6

27

15.9

50

0.51

<0.001

<0.001

 Severe problems

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.7

1

0.0

0

   

Self-care

                      

Women

                      

 Moderate problems

0.0

0

0.0

0

-

0.0

0

0.6

1

1.00

1.1

1

2.3

4

0.43

2.7

3

0.5

1

0.023

0.048

0.059

 Severe problems

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.0

0

0.6

1

 

1.8

2

0.0

0

   

Men

                      

 Moderate problems

1.1

1

0.0

0

0.38

1.8

2

0.9

2

0.61

3.8

5

1.6

4

0.10

3.3

5

1.9

6

0.58

0.37

0.11

 Severe problems

0.0

0

0.0

0

 

0.0

0

0.0

0

 

0.8

1

0.0

0

 

0.7

1

1.0

3

   

Usual activities

                      

Women

                      

 Moderate problems

13.2

7

3.0

3

0.048

12.8

12

7.7

13

0.18

14.9

14

6.4

11

0.029

20.5

23

8.4

16

0.001

0.19

0.42

 Severe problems

0.0

0

1.0

1

 

0.0

0

0.0

0

 

2.1

2

1.7

3

 

2.7

3

1.5

3

   

Men

                      

 Moderate problems

9.1

8

3.4

5

0.033

4.4

5

6.6

14

0.64

9.9

13

7.7

19

0.31

12.4

19

8.6

27

0.14

0.090

0.065

 Severe problems

2.3

2

0.7

1

 

1.8

2

0.9

2

 

2.1

3

1.2

3

 

3.9

6

2.9

9

   

Pain/discomfort

                      

Women

                      

 Moderate problems

28.3

15

25.7

26

0.35

45.7

43

31.5

53

0.050

48.9

46

35.5

61

0.013

51.8

58

47.5

96

0.33

0.041

<0.001

 Severe problems

5.7

3

1.0

1

 

1.1

1

3.0

5

 

5.3

5

2.9

5

 

4.5

5

3.0

6

   

Men

                      

 Moderate problems

22.7

20

24.7

36

0.77

28.9

33

32.4

69

0.41

24.4

32

40.1

99

0.012

49.7

76

44.8

141

0.12

<0.001

<0.001

 Severe problems

2.3

2

2.1

3

 

0.9

1

1.9

4

 

6.1

8

3.6

9

 

7.2

11

4.4

14

   

Anxiety/depression

                      

Women

                      

 Moderate problems

32.0

17

30.7

31

0.60

36.2

34

27.4

46

0.13

38.3

36

29.7

51

0.057

46.4

52

36.0

73

0.056

0.29

0.41

 Severe problems

3.8

2

1.0

1

 

2.1

2

1.8

3

 

8.5

8

5.2

9

 

1.8

2

1.0

2

   

Men

                      

 Moderate problems

28.4

25

23.3

34

0.14

30.7

35

24.9

53

0.13

25.2

33

31.6

78

0.22

31.4

48

23.2

73

0.064

0.43

0.28

 Severe problems

6.8

6

2.7

4

 

3.5

4

1.4

3

 

1.5

2

1.2

3

 

3.3

5

3.2

10

   
  1. a P-value for comparison between patients with diabetes and control individuals (χ2 or Fisher exact test), b p-value for comparison between patients with diabetes in the different cohorts (ANOVA), c p-value for comparison between control individuals in the different cohorts (ANOVA).